Source: International Congress 2019 – Diagnosis of lung cancer
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Hardavella (Athens, Greece), M. Xigki (Athens, Greece), K. Chrysouli (Athens, Greece), A. Pandi (Athens, Greece), I. Karampinis (Athens, Greece), I. Kainis (Athens, Greece). PERC (Pulmonary Embolism Rule-Out Criteria) puzzle in lung cancer (LC) patients and general population. 3070

Member's Comments

No comment yet.

Related content which might interest you: Lung volume reduction coils (LVR-coils) for pulmonary emphysema: Results of the Italian National registry Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Clinical assessment of pulmonary embolism rule-out criteria (PERC). Retrospective study (2006-2015) Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Role of the PE rule-out criteria (PERC) in patients with suspected pulmonary embolism (PE) in a UK District General Hospital Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial Source: Eur Respir J, 56 (4) 2000663; 10.1183/13993003.00663-2020 Year: 2020 Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Advance lung function testing: Lung Volumes(TLC) & Diffusing Capacity(DLco) diagnoses substantial pulmonary function impairment in treated Pulmonary Tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL) Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD) Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Lung cancer in never smokers. An update of the Lung Cancer Risk Factors in Never Smokers Study (LCRINS) Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Pulmonary tuberculosis and lung cancer: A complex interaction Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020 Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients Source: International Congress 2014 – ILDs 6 Year: 2014